我们正在寻找中国人参与临床研究
News
AKL & HAM - 0800 788 3437
CHC & WLG - 0800 862 278

Important Information

If you are interested in applying for this study, please:
  • Read the study description and study information document.
  • Review the Visit Planner dates in your location and confirm that you are available for the stated dates.
  • If you have not yet registered with us, click on the ‘Register’ button at the top of this page and answer the questions.
  • If you have already registered with us, answer the pre-screening questions listed below and submit your interest.

We will then contact you to check your suitability.

Study Information

New Zealand Clinical Research is trialling an investigational medication that is being developed for the suppression of recurrent genital herpes (RGH) in people with Herpes Simplex Virus Type 2 (HSV-2) infection.

HSV-2 infection is spread by sexual contact and can cause painful genital blisters or ulcers (lesions). ABI-1179 is being developed to prevent recurrence of genital herpes due to HSV-2 infection.

HSV-2 affects approximately 15% of New Zealanders and there is currently no cure for the infection. Treatments have been developed to reduce the recurrence and transmission; however, these are only partially effective. ABI-1179 may control HSV-2 by preventing it from reproducing itself (making new copies of the virus) inside the body.

This study will investigate the effects of ABI-1179 in healthy participants (Part A).

It is an investigational drug because it has not been approved by MedSafe or other drug regulatory authorities.

This study (2024 FULL 20918) is being funded by Assembly Biosciences, Inc and has been approved by the Northern B Health and Disability Ethics Committee.

Requirements

Healthy Males and Females

  • Aged between 18 – 60 years old
  • BMI (Body Mass Index) between 18 – 32 kg/m²
  • Non-smokers or Ex-smokers within 3 months allowed
  • Not currently taking any regular prescription medications

What is Involved?

Study Visits: 2 x 5-night stay + 8 clinic visits

Reimbursement: Up to $5,000 before tax

 

Important Documents

Important documents to download and read

Pre-screening Form

Finch

Pre screening for Finch

Personal details

Please provide your name, email and phone number so we can contact you

Medical questions

Have you had any covid symptoms in the last 4 weeks or been in isolation?
This study requires the use of contraception during the study. If you are in a hetereosexual relationship both partners must agree to use contraception (condoms for males | IUD, birth control or another approved form for females). Are you currently using 2 forms of contraception?
Have you previously participated in a study with NZCR or any other organisation?
Do you have any history of medical conditions relating to:
Have you received blood or plasma in the last 90 days? If yes please provide details
Do you have or had any allergies?
Are you currently taking any prescription medication, vitamins, traditional Chinese medicine or minerals?
Have you looked at the study dates and are okay to come in those days? Indicate which group/s you are available for. This means having flexibility for more than one group increases your chances of being accepted into a group.
Just to inform you, that you come in for screening at risk. There is no payment for the screening visit, and you may not be offered a position on the study if the group fills up. It is not guaranteed that you will get a full position on the study as it depends on your results as well. Are you comfortable with this?
Pre-screening form policy(Required)
I understand that by submitting this form, NZCR will use the information for pre-screening purposes for this study. This information may be recorded on your profile to allow us to improve our process when screening you for a future study. All information provided is confidential. I also understand that by submitting this form, I will be receiving emails, texts or calls about this study. For more information, please refer to the Privacy Policy.